Show results for
Refine by
Clinical Routine Suppliers Serving Malta
35 companies found
based inScottsdale, ARIZONA (USA)
Orthoscan was founded in 2002 with one simple idea: develop quality imaging devices that meet our customers´ unique needs. Starting with our first mini C-arm, the Orthoscan Ultra Compact, we have continued that commitment by providing ...
With its all-in-one design, the Ziehm Solo FD is one of the most compact C-arms on the market – now equipped with CMOSline flat-panel technology to perform a broad portfolio of applications. Versatile viewing options and new dimensions in user ...
based inGräfelfing/Munich, GERMANY
Economical, validated and reliable methods for clinical HPLC and LC-MS/MS combined with professional support - that's the key for success at Chromsystems. All products are developed and manufactured in Gräfelfing near Munich, Germany, and are ...
based inPlanegg, GERMANY
We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound ...
This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. ...
based inHeidelberg, GERMANY
Molecular Health is an international biotech IT company based in Heidelberg, Germany, that has been developing innovative software in the areas of in silico and precision medicine since 2004. Molecular Health’s solutions make it possible to ...
Use worldwide knowledge to reliably determine the risk of genetic disease. MH Guide/Mendel is optimized for the evaluation of germline variants associated with hereditary diseases. The software application is a module of MH Guide and supports human ...
based in, INDIA
inDNA Research Labs is an early stage big-data analytics healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by ...
based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
Oncosome.HER2 is a liquid biopsy diagnostic for the detection of HER2 in blood to identify patients eligible for HER2 targeted therapy. Oncosome.HER2 would address an high unmet medical ...
based inVolketswil, SWITZERLAND
Hocoma AG is a global leader specializing in the development and manufacturing of cutting-edge robotic and sensor-based devices for functional movement therapy. The company is dedicated to improving millions of lives by setting high standards in ...
Clinical integration is a continuous process in which the uptake of rehabilitation technologies into the clinical setting is facilitated in order to deliver safe, timely, effective, efficient and patient-focused care. Hocoma’s clinical ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
based inEmmendingen, GERMANY
Biomedical technology – developed and manufactured in Germany: inomed is the first choice for medical specialists worldwide. Cost-effective clinical outcomes and patient safety are the highest priorities in today's healthcare environment. Biomedical ...
Measurement modalities from MEP to SEP, Individually configurable, Easy to handle, Complete package for your IOM, With the systems of the ISIS IOM family inomed offers a complete package for multimodal intraoperative neurophysiological monitoring ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
based inHeidelberg, GERMANY
Since 25 years we develop, produce and sell our innovative products for various fields of medical and laser technology. In 2020 we celebrate our 25th anniversary. MRC Systems GmbH was established in 1995 as a spin-off of the University of Heidelberg ...
One set includes seven weighted pinprick stimulators for different pressures (between 8mN and 512mN). Tips have a flat contact area of 0.25mm in diameter with a controlled edge ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also ...
based inGieres, FRANCE
eCential Robotics has developed the first platform unifying 2D Fluoroscopy, 3D Imaging and real-time Navigation. eCential Robotics facilitates Less Invasive Surgery in clinical routine, supporting the development of outpatient surgery and offering ...
based inJena, GERMANY
Imedos is the leading expert in microcirculation and microvascular health of the retina. For more than 25 years, we have been developing and distributing innovative systems for research in the field of ...
The aim of dynamic vascular analysis (DVA) is to examine the condition and function of the retinal vessels by measuring their diameter. We measure the vessel diameters because they are the actuators of autoregulation and reflect regulatory effects. ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS ...
based inWixom, MICHIGAN (USA)
DiaSys Diagnostic Systems emerged as pioneer in the field of liquid stable reagents and has developed to an established provider of diagnostic solutions for the clinical laboratory. DiaSys develops, manufactures and markets diagnostic systems of ...
based inPadova (PD), ITALY
Khymeia Group was established in 1998 following fundamental studies in the fields of neurological rehabilitation medicine, conducted for years by Dr. Lamberto Piron in the Department of Cognitive Science Professor led by Emilio Bizzi at MIT – ...
VRRS Evo is an internationally patented Class I medical device. The most advanced, complete, and clinically proven virtual reality system for rehabilitation and tele-rehabilitation in the world. The extreme ease of use, the vast library of ...
based inCambridge, UNITED KINGDOM
CMR takes pride in the diligence, care and attention we pay to the way we handle all customer and patient data to enable us to provide the digital services and products we build and run. Security and privacy are built into our solutions from the ...
based inLeiden, NETHERLANDS
Medis was created in 1989 as a spin-off of the Leiden University Medical Centre (LUMC Netherlands). Our founder and current CSO, Hans Reiber, built the company focusing on X-ray and image analysis of the heart with the mission to make these tools ...
The innovative, vendor-independent post-processing software solution for advanced quantitative analysis of cardiovascular CT ...
based inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Multiple sclerosis (MS) affects an estimated 2.5 million people worldwide. It is the most widespread disabling neurological condition of young adults. MS develops at any age, but most people are diagnosed between ages of 20 and 50. There is ...